Showing results (11-20 of 253) with videos related to
Sort By:
Pageof 26
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 1, 2013
HLA engineering of human pluripotent stem cellsLaura Riolobos, Roli K Hirata, Cameron J Turtle, et al.International Journal of Hematology|December 17, 2013
Chimeric antigen receptor modified T cell therapy for B cell malignanciesCameron J TurtleScience Translational Medicine|September 3, 2010
Overlap and effective size of the human CD8+ T cell receptor repertoireHarlan S Robins, Santosh K Srivastava, Paulo V Campregher, et al.Blood|February 16, 2013
Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivoSuzanne M McGoldrick, Marie E Bleakley, Abraham Guerrero, et al.The Journal of Experimental Medicine|December 22, 2004
Finding a place for tumor-specific T cells in targeted cancer therapyStanley R RiddellJournal of Immunology (Baltimore, Md. : 1950)|December 14, 2018
Cytomegalovirus Exposure in the Elderly Does Not Reduce CD8 T Cell Repertoire DiversityPaul Lindau, Rithun Mukherjee, Miriam V Gutschow, et al.Hematology. American Society of Hematology. Education Program|November 21, 2007
Engineering antitumor immunity by T-cell adoptive immunotherapyStanley R RiddellBlood|August 27, 2009
Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cellsHarlan S Robins, Paulo V Campregher, Santosh K Srivastava, et al.Blood|July 28, 2011
Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161(hi) CD8α⁺ semi-invariant T cellsCameron J Turtle, Jeff Delrow, Rochelle C Joslyn, et al.Cancer Journal (Sudbury, Mass.)|March 22, 2021
Chimeric Antigen Receptor T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: Current Landscape in 2021Jordan Gauthier, Cameron J TurtlePageof 26